Search - tctmd.com

Displaying 141 - 160 of 237

Sort: Relevancy | Date

Presentation CRT 2016

CardiAQ-Edwards TMVR

Presenter: Howard C. Herrmann

February 19, 2016

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Presenter: John D. Carroll, Ioanna Kosmidou, Howard C. Herrmann

October 15, 2015

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Presenter: Howard C. Herrmann

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

Presentation TCT 2015

MitraSpan Transapical Segmented Reduction Annuloplasty (TASRA): Rationale and FIM Results

Presenter: Steven L. Goldberg, Joachim Schofer, Howard C. Herrmann

October 14, 2015

Presentation TCT 2015

Complications After MitraClip: Frequency, Avoidance, and Treatment

Presenter: Stephan Baldus, Saibal Kar, Howard C. Herrmann

October 14, 2015

Presentation TCT 2015

Case 1: Transseptal Puncture With MitraClip

Presenter: Ted E. Feldman, Samir R. Kapadia, Saibal Kar, Howard C. Herrmann

October 13, 2015

Presentation TCT 2015

Low Flow: Low-Gradient Aortic Stenosis and TAVR Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara

October 12, 2015

Presentation TCT 2015

Low Flow: Low-Gradient Aortic Stenosis and TAVR Case Presentation

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Chet Rihal

October 12, 2015

Presentation TCT 2015

Poor Femoral Access and TAVR (Alternative Access): Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Michael J. Reardon

October 12, 2015

Presentation TCT 2015

Poor Femoral Access and TAVR (Alternative Access): Case Presentation

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Richard Smalling

October 12, 2015

Presentation TCT 2015

Bioprosthetic Aortic Valve Failure and TAVR: Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Vinayak Bapat

October 12, 2015

Presentation TCT 2015

Bioprosthetic Aortic Valve Failure and TAVR: Case Presentation

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Stephen R. Ramee

October 12, 2015

Presentation TCT 2015

Aortic Stenosis With Extreme Comorbidities (the Futile Patient): Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Robert A. Guyton

October 12, 2015

Presentation TCT 2015

Aortic Stenosis With Extreme Comorbidities (the Futile Patient): Case Presentation

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Neal S. Kleiman

October 12, 2015

Presentation TCT 2015

Severe Renal Disease and TAVR: Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Charles J. Davidson

October 12, 2015

Presentation TCT 2015

Severe Renal Disease and TAVR: Case Presentation

Presenter: Howard C. Herrmann, Patrick T. O'Gara, S. Chiu Wong

October 12, 2015

Presentation TCT 2015

Severe Frailty With Aortic Stenosis and TAVR: Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Jeffrey J. Popma

October 12, 2015

Advertisement

CardiAQ-Edwards TMVR

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

MitraSpan Transapical Segmented Reduction Annuloplasty (TASRA): Rationale and FIM Results

Complications After MitraClip: Frequency, Avoidance, and Treatment

Case 1: Transseptal Puncture With MitraClip

Low Flow: Low-Gradient Aortic Stenosis and TAVR Thoughtful Commentary on the Case

Low Flow: Low-Gradient Aortic Stenosis and TAVR Case Presentation

Poor Femoral Access and TAVR (Alternative Access): Thoughtful Commentary on the Case

Poor Femoral Access and TAVR (Alternative Access): Case Presentation

Bioprosthetic Aortic Valve Failure and TAVR: Thoughtful Commentary on the Case

Bioprosthetic Aortic Valve Failure and TAVR: Case Presentation

Aortic Stenosis With Extreme Comorbidities (the Futile Patient): Thoughtful Commentary on the Case

Aortic Stenosis With Extreme Comorbidities (the Futile Patient): Case Presentation

Severe Renal Disease and TAVR: Thoughtful Commentary on the Case

Severe Renal Disease and TAVR: Case Presentation

Severe Frailty With Aortic Stenosis and TAVR: Thoughtful Commentary on the Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content